Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Mosnaim

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Hospital & Community Psychiatry|August 1, 1984
Identifying subtypes of tardive dyskinesiaM E Wolf, A D Mosnaim
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Improvement of axial dystonia with the administration of clozapineM E Wolf, A D Mosnaim
Journal of Clinical Psychopharmacology|August 1, 1988
Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesiaA D Mosnaim, M E Wolf
General Pharmacology|January 1, 1983
Phenylethylamine in neuropsychiatric disordersM E Wolf, A D Mosnaim
Brain Research|September 10, 1976
Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brainR P Silkaitis, A D Mosnaim
The American Journal of Psychiatry|June 1, 1974
Phenylethylamine hypothesis of affective behaviorH C Sabelli, A D Mosnaim
Analytical Biochemistry|August 1, 1973
A spectrophotometric method for the quantification of 2-phenylethylamine in biological specimensA D Mosnaim, E E Inwang
European Journal of Pharmacology|May 2, 1980
Direct effect of phenylethylamine upon isolated rat aortic stripT R Hansen, J Greenberg, A D Mosnaim
Research Communications in Chemical Pathology and Pharmacology|May 1, 1976
Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrierW A Pedemonte, A D Mosnaim, M Bulat
Research Communications in Chemical Pathology and Pharmacology|January 1, 1989
Blood-brain barrier passage of azidothymidine in rats: effect of insulinS G Ayre, B Skaletski, A D Mosnaim
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Hospital & Community Psychiatry|August 1, 1984
Identifying subtypes of tardive dyskinesiaM E Wolf, A D Mosnaim
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
Improvement of axial dystonia with the administration of clozapineM E Wolf, A D Mosnaim
Journal of Clinical Psychopharmacology|August 1, 1988
Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesiaA D Mosnaim, M E Wolf
General Pharmacology|January 1, 1983
Phenylethylamine in neuropsychiatric disordersM E Wolf, A D Mosnaim
Brain Research|September 10, 1976
Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brainR P Silkaitis, A D Mosnaim
The American Journal of Psychiatry|June 1, 1974
Phenylethylamine hypothesis of affective behaviorH C Sabelli, A D Mosnaim
Analytical Biochemistry|August 1, 1973
A spectrophotometric method for the quantification of 2-phenylethylamine in biological specimensA D Mosnaim, E E Inwang
European Journal of Pharmacology|May 2, 1980
Direct effect of phenylethylamine upon isolated rat aortic stripT R Hansen, J Greenberg, A D Mosnaim
Research Communications in Chemical Pathology and Pharmacology|May 1, 1976
Penetration of phenylacetic acid across the blood-cerebrospinal fluid barrierW A Pedemonte, A D Mosnaim, M Bulat
Research Communications in Chemical Pathology and Pharmacology|January 1, 1989
Blood-brain barrier passage of azidothymidine in rats: effect of insulinS G Ayre, B Skaletski, A D Mosnaim
Pageof 8